# Amy Mahery

> Amy Mahery is a Boston-based biopharmaceutical executive whose career has crossed field sales, brand marketing, pricing, market access, global franchise leadership, startup commercialization, and board service. A neuroscience graduate who once expected to attend medical school, she entered the industry after a memorable airport-lounge interview and built a leadership philosophy around curiosity, cross-functional fluency, transparent information, and bringing commercial thinking into R&D early. She became Moderna's senior vice president and chief marketing officer in February 2025 after leadership roles at Johnson & Johnson, EMD Serono, Roivant Sciences, and Pulmovant, and she has served on the CNS Pharmaceuticals board since 2024.

- **Role:** Senior Vice President and Chief Marketing Officer at Moderna
- **Organizations:** Moderna, CNS Pharmaceuticals, Roivant Sciences, Pulmovant, EMD Serono, Merck KGaA, Johnson & Johnson, Trinity College-Hartford
- **Education:** Bachelor of Science in neuroscience, Trinity College-Hartford
- **Known for:** Named a 2021 Women Worth Watching award recipient by Profiles in Diversity Journal., Joined the CNS Pharmaceuticals board of directors in 2024., Became Roivant Sciences' first chief commercial officer in 2022.

## Career timeline

- **Early career** — Began in field sales at Johnson & Johnson after graduating from Trinity College-Hartford.
- **2004** — Joined EMD Serono and went on to hold roles across marketing and market access.
- **2019** — Appointed global head of market access and pricing for the healthcare business of Merck KGaA, Darmstadt, Germany.
- **2021** — Served as senior vice president and global franchise head for neurology and immunology at EMD Serono.
- **2022** — Joined Roivant Sciences as its first chief commercial officer.
- **2024** — Joined the CNS Pharmaceuticals board of directors and later moved into the chief commercial officer role at Pulmovant within the Roivant portfolio.
- **2025** — Joined Moderna as senior vice president and chief marketing officer.

## Achievements

- Named a 2021 Women Worth Watching award recipient by Profiles in Diversity Journal.
- Joined the CNS Pharmaceuticals board of directors in 2024.
- Became Roivant Sciences' first chief commercial officer in 2022.
- Received a President's Award at EMD Serono.
- Received first place in the DX Creative Communications Awards for interactive education.
- Received an Rx Club Award of Excellence for a healthcare professional website.
- Founded a Women in Leadership community outreach initiative at EMD Serono.

## Latest updates

- **2025-02** — Joined Moderna as senior vice president and chief marketing officer.
- **2024-09** — Moved into a chief commercial officer role at Pulmovant after helping with diligence and startup work inside the Roivant portfolio.
- **2024-02** — Began serving as a director of CNS Pharmaceuticals.

## Links

- Website: https://www.modernatx.com
- LinkedIn: https://www.linkedin.com/in/amy-mahery

---

Profile page: https://yespress.io/amy-mahery
Published by YesPress — https://yespress.io
Last updated: 2026-08-14